Salvato in:
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Journal of natural products
2025
|
| Soggetti: | |
| Accesso online: | https://pubmed.ncbi.nlm.nih.gov/40490901/ |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Sommario:
- Zoanthamine-Type Alkaloids Derived from Cultured with Therapeutic Potential Against Osteoporosis. Pham, Ngoc-Thac Peng, Bo-Rong Le, Huong-Giang Cheng, You-Song Chen, Yun-Shiuan Huynh, Thanh Hao Chen, Lo-Yun Nguyen, Le Anh Tuan Nguyen, Dang T Chang, Yu-Chia Su, Jui-Hsin El-Shazly, Mohamed Lee, Mei-Hsien Lai, Kuei-Hung Alkaloids Osteoporosis Humans Molecular Structure Extracts of the zoanthid from (ZK) exhibited significant antiosteoporotic activity in MG-63 cells, prompting the use of Global Natural Products Social Molecular Networking (GNPS) to identify alkaloid-rich fractions. Subsequently, five new zoanthamine-type alkaloids, norzoabenzaldehyde (), norzoazepanol (), 3-acetoxynorzoanthaminone (), 11-hydroxynorzoanthamide B (), and 11-hydroxyzoanthamide B (), were isolated. Structural elucidation was achieved by spectroscopic analyses, time-dependent density functional theory nuclear magnetic resonance (TDDFT-NMR) calculations, and electronic circular dichroism (ECD). The alkaloid 3-hydroxynorzoanthamine exhibited notable alkaline phosphatase activity and promoted mineralization, with an IC value of 20 μM, underscoring its potential as a promising lead compound for the development of osteoporosis therapeutics.